Anxious Behavior and Fenfluramine-Induced Prolactin Secretion in Young Rhesus Macaques with Different Alleles of the Serotonin Reuptake Transporter Polymorphism (5HTTLPR)

Anxiety is a normal aspect of human personality, which can manifest in a variety of disorders and other negative traits. The primary treatment for anxiety is the class of drugs known as the selective serotonin reuptake inhibitors (SSRIs), which bind to the serotonin reuptake transporter. The upstream region of the gene that codes for this transporter contains a polymorphism that is an insertion/deletion event that in turn, produces long (l) and short (s) alleles in the population. This particular polymorphism in the serotonin transporter, the 5HTTLPR (serotonin transporter linked polymorphic region), is thought to be involved in the genesis of anxious traits and disorders. Most studies with human subjects have examined adult behavior, which may derive from diverse experiential and environmental backgrounds, as well as genetic differences. To better isolate the effect of genetics, we genotyped 128 infant and juvenile monkeys for the 5HTTLPR and tested for behavioral response in four testing paradigms designed to elicit fearful-anxious behaviors: a free play, remote-controlled car, human intruder, and novel fruit test. The s/s monkeys were found to be behaviorally inhibited in the free play test, engaged in more fear behaviors in the remote-controlled car test, and threatened more in the stare portion of the human intruder test, even though a small number of monkeys were assessed. There was no difference between genotypes of either sex in the prolactin response to fenfluramine. These data indicate greater anxiety in the s/s monkeys for distinct facets of anxious behavior, which are independent of a global neurohormonal challenge test. These neurobehavioral data support recent neuroimaging findings in humans indicating the importance of the 5HTTLPR for amygdala-dependent anxious behavior.

[1]  E. Smeraldi,et al.  Polymorphism within the promoter of the serotonin transporter gene and antidepressant efficacy of fluvoxamine , 1998, Molecular Psychiatry.

[2]  S. Shelton,et al.  Defensive behaviors in infant rhesus monkeys: environmental cues and neurochemical regulation. , 1989, Science.

[3]  S. Roose.  Treating sexual dysfunction: psychiatry's role in the age of sildenafil. , 2002, The Journal of clinical psychiatry.

[4]  M. Prior,et al.  Association of a functional polymorphism of the serotonin transporter gene with anxiety-related temperament and behavior problems in children: a longitudinal study from infancy to the mid-teens , 2000, Molecular Psychiatry.

[5]  C Reist,et al.  Serotonin transporter promoter polymorphism is associated with attenuated prolactin response to fenfluramine. , 2001, American journal of medical genetics.

[6]  Boris Barbour,et al.  Nonvesicular release of neurotransmitter , 1993, Neuron.

[7]  G. Sackett,et al.  Behavioral measurement of temperament in male nursery‐raised infant macaques and baboons , 1999, American journal of primatology.

[8]  K. Lesch,et al.  Serotonin transporter gene polymorphism, differential early rearing, and behavior in rhesus monkey neonates , 2002, Molecular Psychiatry.

[9]  Scott F. Hall,et al.  Barrel Pattern Formation Requires Serotonin Uptake by Thalamocortical Afferents, and Not Vesicular Monoamine Release , 2001, The Journal of Neuroscience.

[10]  K. Lesch,et al.  Association of Anxiety-Related Traits with a Polymorphism in the Serotonin Transporter Gene Regulatory Region , 1996, Science.

[11]  Dennis L. Murphy,et al.  Excessive Activation of Serotonin (5-HT) 1B Receptors Disrupts the Formation of Sensory Maps in Monoamine Oxidase A and 5-HT Transporter Knock-Out Mice , 2001, The Journal of Neuroscience.

[12]  Anantha Shekhar,et al.  A psychobiological approach to personality: examination within anxious outpatients. , 2002, Journal of psychiatric research.

[13]  D. Hirshfeld-Becker,et al.  The developmental psychopathology of social anxiety disorder , 2002, Biological Psychiatry.

[14]  G. Rudnick,et al.  The molecular mechanism of "ecstasy" [3,4-methylenedioxy-methamphetamine (MDMA)]: serotonin transporters are targets for MDMA-induced serotonin release. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[15]  T. Dinan,et al.  Prolactin and cortisol responses to d-fenfluramine in major depression: evidence for diminished responsivity of central serotonergic function. , 1991, The American journal of psychiatry.

[16]  E. A. Schwartz,et al.  Depolarization without calcium can release gamma-aminobutyric acid from a retinal neuron. , 1987, Science.

[17]  M. Reite,et al.  Juvenile Friends, Behavior, and Immune Responses to Separation in Bonnet Macaque Infants , 1997, Physiology & Behavior.

[18]  J. Lauder,et al.  Serotonin as a regulator of craniofacial morphogenesis: site specific malformations following exposure to serotonin uptake inhibitors. , 1992, Teratology.

[19]  J. Ballenger.  Overview of different pharmacotherapies for attaining remission in generalized anxiety disorder. , 2001, The Journal of clinical psychiatry.

[20]  H. C. Hartzell,et al.  Molecular physiology of norepinephrine and serotonin transporters. , 1994, The Journal of experimental biology.

[21]  M. Owen,et al.  The genetic basis of complex human behaviors. , 1994, Science.

[22]  A. Shalev.  What is posttraumatic stress disorder? , 2001, The Journal of clinical psychiatry.

[23]  P Riederer,et al.  Allelic Variation of Human Serotonin Transporter Gene Expression , 1996, Journal of neurochemistry.

[24]  B. Bondy,et al.  Possible association of the short allele of the serotonin transporter promoter gene polymorphism (5-HTTLPR) with violent suicide , 2000, Molecular Psychiatry.

[25]  B. Lerer,et al.  Evaluation of central serotonergic function in affective and related disorders by the fenfluramine challenge test: a critical review. , 1998, The international journal of neuropsychopharmacology.

[26]  D. Murphy,et al.  Plasma prolactin changes following fenfluramine in depressed patients compared to controls: an evaluation of central serotonergic responsivity in depression. , 1984, Life sciences.

[27]  I. Waldman,et al.  Genetic and Environmental Influences on Separation Anxiety Disorder Symptoms and Their Moderation by Age and Sex , 2001, Behavior genetics.

[28]  C. M. Berman,et al.  Changes in yearling rhesus monkeys’ relationships with their mothers after sibling birth , 2001, American journal of primatology.

[29]  L. Parsons,et al.  Anxiogenic-like effect of serotonin1B receptor stimulation in the rat elevated plus-maze , 2002, Pharmacology Biochemistry and Behavior.

[30]  E. Shimizu,et al.  Study of the association between the serotonin transporter gene regulatory region polymorphism and personality traits in a Japanese population , 1999, Neuroscience Letters.

[31]  Y. Osher,et al.  Association and linkage of anxiety-related traits with a functional polymorphism of the serotonin transporter gene regulatory region in Israeli sibling pairs , 2000, Molecular Psychiatry.

[32]  J. Boulenger,et al.  Association between violent suicidal behavior and the low activity allele of the serotonin transporter gene , 2001, Molecular Psychiatry.

[33]  I. McGregor,et al.  Increased anxiety and impaired memory in rats 3 months after administration of 3,4-methylenedioxymethamphetamine ("ecstasy"). , 2001, European journal of pharmacology.

[34]  J. Endicott,et al.  Blunted serotonin response to fenfluramine challenge in premenstrual dysphoric disorder. , 1997, The American journal of psychiatry.

[35]  G. Perugi,et al.  Reboxetine, a selective norepinephrine reuptake inhibitor, is an effective and well-tolerated treatment for panic disorder. , 2002, The Journal of clinical psychiatry.

[36]  Annemarie Poustka,et al.  The 5-HT transporter gene-linked polymorphic region (5-HTTLPR) in evolutionary perspective: Alternative biallelic variation in rhesus monkeys , 2005, Journal of Neural Transmission.

[37]  B. Falkenburger,et al.  Dendrodendritic Inhibition Through Reversal of Dopamine Transport , 2001, Science.

[38]  Silviu-Alin Bacanu,et al.  Heritability of fearful-anxious endophenotypes in infant rhesus macaques: a preliminary report , 2003, Biological Psychiatry.

[39]  R. Murray,et al.  Assessment of serotonergic function in major depression using d-fenfluramine: relation to clinical variables and antidepressant response , 1998, Biological Psychiatry.

[40]  R. Rothman,et al.  Serotonin releasing agents Neurochemical, therapeutic and adverse effects , 2002, Pharmacology Biochemistry and Behavior.

[41]  A. Reiss,et al.  The influence of environmental and genetic factors on behavior problems and autistic symptoms in boys and girls with fragile X syndrome. , 2001, Pediatrics.

[42]  A. Rush,et al.  Overview of psychiatric disorders and the role of newer antidepressants. , 2002, The Journal of clinical psychiatry.

[43]  M. Egan,et al.  Serotonin Transporter Genetic Variation and the Response of the Human Amygdala , 2002, Science.

[44]  N. Kalin.  Nonhuman primate studies of fear, anxiety, and temperament and the role of benzodiazepine receptors and GABA systems. , 2003, The Journal of clinical psychiatry.

[45]  H. Goldsmith,et al.  Temperament as a potential developmental influence on attachment. , 1986, New directions for child development.

[46]  D. Roberts,et al.  The statistical program SYSTAT : Wilkinson, L. (1986). SYSTAT, The System for Statistics. SYSTAT, Inc. 2902 Central Street, Evanston, IL 60201. , 1987 .

[47]  H. Rytsälä,et al.  Current comorbidity of psychiatric disorders among DSM-IV major depressive disorder patients in psychiatric care in the Vantaa Depression Study. , 2002, The Journal of clinical psychiatry.

[48]  K. Neve,et al.  Release of dopamine via the human transporter. , 1994, Molecular pharmacology.

[49]  K. Kobak,et al.  Behavior therapy for obsessive-compulsive disorder guided by a computer or by a clinician compared with relaxation as a control. , 2002, The Journal of clinical psychiatry.